188 related articles for article (PubMed ID: 15771616)
21. The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants.
D'Alessio A; Califano D; Incoronato M; Santelli G; Florio T; Schettini G; Carlomagno MS; Cerchia L; de Franciscis V
Endocrinology; 2003 Oct; 144(10):4298-305. PubMed ID: 12959980
[TBL] [Abstract][Full Text] [Related]
22. Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases.
Ahmed SA; Snow-Bailey K; Highsmith WE; Sun W; Fenwick RG; Mao R
J Mol Diagn; 2005 May; 7(2):283-8. PubMed ID: 15858153
[TBL] [Abstract][Full Text] [Related]
23. A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients.
Gartner W; Mineva I; Daneva T; Baumgartner-Parzer S; Niederle B; Vierhapper H; Weissel M; Wagner L
Hum Genet; 2005 Jul; 117(2-3):143-53. PubMed ID: 15841388
[TBL] [Abstract][Full Text] [Related]
24. The RET receptor is linked to stress response pathways.
Myers SM; Mulligan LM
Cancer Res; 2004 Jul; 64(13):4453-63. PubMed ID: 15231654
[TBL] [Abstract][Full Text] [Related]
25. Gene therapeutic approaches for medullary thyroid carcinoma treatment.
Drosten M; Pützer BM
J Mol Med (Berl); 2003 Jul; 81(7):411-9. PubMed ID: 12811413
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathogenesis of MEN2-associated tumors.
Koch CA
Fam Cancer; 2005; 4(1):3-7. PubMed ID: 15883703
[TBL] [Abstract][Full Text] [Related]
27. RET/PTC oncoproteins: molecular targets of new drugs.
Lanzi C; Cassinelli G; Cuccuru G; Zanchi C; Laccabue D; Zunino F
Tumori; 2003; 89(5):520-2. PubMed ID: 14870776
[TBL] [Abstract][Full Text] [Related]
28. RET signaling in endocrine tumors: delving deeper into molecular mechanisms.
Lai AZ; Gujral TS; Mulligan LM
Endocr Pathol; 2007; 18(2):57-67. PubMed ID: 17916994
[TBL] [Abstract][Full Text] [Related]
29. Development of RET kinase inhibitors for targeted cancer therapy.
Mologni L
Curr Med Chem; 2011; 18(2):162-75. PubMed ID: 21110809
[TBL] [Abstract][Full Text] [Related]
30. The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
De Falco V; Carlomagno F; Li HY; Santoro M
Best Pract Res Clin Endocrinol Metab; 2017 Jun; 31(3):307-318. PubMed ID: 28911727
[TBL] [Abstract][Full Text] [Related]
31. Pyrosequencing and Mayo Clinic collaborate on diagnostic tests.
Expert Rev Mol Diagn; 2002 Jan; 2(1):5. PubMed ID: 11963804
[No Abstract] [Full Text] [Related]
32. New approaches to thyroid cancer.
Cohen EE
Clin Adv Hematol Oncol; 2012 Apr; 10(4):255-6. PubMed ID: 22706487
[No Abstract] [Full Text] [Related]
33. State-of-the-Art Strategies for Targeting
Subbiah V; Yang D; Velcheti V; Drilon A; Meric-Bernstam F
J Clin Oncol; 2020 Apr; 38(11):1209-1221. PubMed ID: 32083997
[TBL] [Abstract][Full Text] [Related]
34. RET kinase inhibitors: a review of recent patents (2012-2015).
Mologni L; Gambacorti-Passerini C; Goekjian P; Scapozza L
Expert Opin Ther Pat; 2017 Jan; 27(1):91-99. PubMed ID: 27646564
[TBL] [Abstract][Full Text] [Related]
35. [RET Gene Alterations in Thyroid Cancer-Towards Treatment with Selective RET Inhibitors].
Mitsutake N; Nakamura K; Suzuki S
Gan To Kagaku Ryoho; 2023 May; 50(5):611-614. PubMed ID: 37218322
[TBL] [Abstract][Full Text] [Related]
36. ROS receptor tyrosine kinase: a new potential target for anticancer drugs.
El-Deeb IM; Yoo KH; Lee SH
Med Res Rev; 2011 Sep; 31(5):794-818. PubMed ID: 20687158
[TBL] [Abstract][Full Text] [Related]
37. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.
Ye L; Santarpia L; Gagel RF
Endocr Rev; 2010 Aug; 31(4):578-99. PubMed ID: 20605972
[TBL] [Abstract][Full Text] [Related]
38. Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors.
Bhujbal SP; Keretsu S; Cho SJ
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525725
[TBL] [Abstract][Full Text] [Related]
39. REToma: a cancer subtype with a shared driver oncogene.
Kohno T; Tabata J; Nakaoku T
Carcinogenesis; 2020 Apr; 41(2):123-129. PubMed ID: 31711124
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of RET signaling in cancer: current and future implications for targeted therapy.
Plaza-Menacho I; Mologni L; McDonald NQ
Cell Signal; 2014 Aug; 26(8):1743-52. PubMed ID: 24705026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
